Sanger Leadership Team

The Sanger Leadership Team is an Executive Committee that reports to the Director and the Genome Research Limited (GRL) Board. It is designed to enable holistic and effective decision making, with transparency and accountability woven into its make up. The Committee is made up of senior leaders that are tasked with making significant and sound decisions in the best interest of Sanger as it supports and delivers its scientific mission and positively influences Sanger’s organisational culture with a focus on equality, diversity and inclusion.

Membership

Chair

Wellcome Sanger Institute Director

Professor Matthew Hurles

Secretariat

 

 

Executive Assistant to Wellcome Sanger Institute Director

Katharine Sparrow

Members

Deputy Chair

Director of Strategy, Policy and Innovation

Dr Julia Wilson

 

Interim Director of Connecting Science

Dr Ireena Dutta

 

Head of the Cancer, Ageing and Somatic Mutation Programme

Dr Peter Campbell

 

Head of the Parasites and Microbes Programme

Professor Nicholas Thomson

 

Interim Head of Human Genetics Programme

Dr Carl Anderson

 

Interim Head of Cellular Genetics Programme

Professor Muzlifah Haniffa

 

Head of Tree of Life Programme

Professor Mark Blaxter

 

Director of Scientific Operations

Dr Cordelia Langford

 

Chief Operating Officer

Dr Martin Dougherty

 

Chief Finance Officer

Ms Maggie Payne

 

Director of Human Resources

Charlie Weatherhogg

 

Chief Information Officer

Dr James McCafferty

 

General Counsel and Company Secretary

Nadia Meliti

Standing Attendees

Head of Strategy

Johanna Staines

 

Employee Partnership Chair

Briony Clarke

 

Chief of Staff to Sanger Director

Carl Logan

Head of Translation

Dr Emmanuelle Astoul

 

Director of Communications

Steve Palmer

 

[Standing attendees do not have a vote but their input is critical in informing decisions and help bring a wider perspective.]

Observers

Wellcome Representative

Related Sanger Institute Governance